Manoj J. Monga, MD, FACS, FRCS

Manoj J. Monga, MD, FACS, FRCS

The University of California, San Diego

San Diego, California

Manoj J. Monga, MD, FACS, FRCS, is a Professor and the Chair of the Department of Urology at the University of California, San Diego, where he oversees the department’s research, teaching, and clinical care. He is recognized as an international authority in endourology (minimally invasive urologic surgery) and kidney stone disease. His clinical expertise includes kidney stone prevention, medical and surgical management of kidney stone disease, and endoscopic management of upper tract transitional cell cancer and benign strictures.

Dr. Monga earned his medical degree from the University of Health Sciences Chicago Medical School in North Chicago, Illinois. He completed a fellowship and residency in General Surgery and a residency in Urology at Tulane University in New Orleans, Louisiana.

Dr. Monga has over 400 peer-reviewed manuscripts, and his work has been included in publications including the Journal of Endourology, the Journal of Urology, Gastroenterology Research, Urology Practice, and the International Journal of Microbial Ecology. He has co-edited books on ureteroscopy, endourology, dietary stone prevention, and percutaneous renal surgery, and has contributed chapters to more than 40 books. Dr. Monga has innovated and developed medical devices related to the treatment of kidney stones, lectured on endourology and stone disease at national and global events, and volunteered for urology missions at hospitals in India and Ukraine. He previously served as Secretary of the American Urological Association, where he advocated for racial and gender diversity and shared governance within the field and organization. Dr. Monga currently serves on the American College of Surgeons’ Board of Governors.

Talks by Manoj J. Monga, MD, FACS, FRCS

Controversies in Percutaneous Nephrolithotomy

Manoj J. Monga, MD, FACS examines the indications for PCNL, emphasizing the criteria that influence the decision to opt for this invasive treatment. He highlights differing opinions on patient selection and the importance of individualized treatment plans.

Dr. Monga focuses on the technical aspects of PCNL and various approaches and techniques. He reviews the debate over the optimal access points, upper pole versus lower pole entry, and the risks and benefits of miniaturized versus standard tracts. He analyzes outcomes related to stone clearance rates, complications, and recovery times. Dr. Monga further explores the controversies in postoperative management, particularly the use of nephrostomy tubes versus tubeless procedures.

Emerging technologies and innovations in PCNL are also a key part of this presentation. Advancements in imaging techniques, new instruments, and their potential to enhance the safety and effectiveness of the procedure are examined, as well as the need for ongoing research.

Read More